Department of Podiatry, School of Clinical Sciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
Department of Surgery, School of Clinical Sciences, Faculty of Medicine, Nursing and Allied Health, Monash University, Clayton, Victoria, Australia.
J Ren Care. 2024 Dec;50(4):513-528. doi: 10.1111/jorc.12514. Epub 2024 Nov 6.
Current guidelines for noninvasive lower limb vascular testing specify a preference for toe brachial pressure measurement to aid in the diagnosis of peripheral arterial disease populations with high suspicion of peripheral vessel calcification, such as those with kidney failure with replacement therapy.
The aim was to identify the current literature on toe systolic blood pressure and toe brachial pressure index for individuals with kidney failure who are receiving replacement therapy.
A scoping review.
MEDLINE, CINAHL, AMED and SPORTDiscus were systematically searched between July 15 and July 30, 2023. The scoping review followed the Arksey and O'Malley framework, with data reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping reviews.
Sixteen studies were included in the review. There was limited data examining the significance of toe systolic blood pressure and toe brachial pressure index during a dialysis session. There were differences in the normative values for toe brachial pressure index values used in the studies and limited reporting on the measurement protocols used to determine toe systolic blood pressure and toe brachial pressure index.
The review found limited data examining the clinical utility of toe systolic blood pressure and toe brachial pressure index in populations receiving dialysis. The use of toe systolic blood pressure and toe-brachial index to identify peripheral artery disease in this population is important. However, there is limited evidence and conflicting information on measurement protocols, reliability, diagnostic accuracy, and prognostic capacity.
目前针对非侵入性下肢血管检测的指南规定,对于外周血管钙化高度怀疑的外周动脉疾病患者群体,如正在接受肾替代治疗的肾衰竭患者,推荐使用趾肱血压测量来辅助诊断。
旨在确定目前关于正在接受肾替代治疗的肾衰竭患者的趾收缩压和趾肱血压指数的文献。
范围综述。
系统检索了 MEDLINE、CINAHL、AMED 和 SPORTDiscus 数据库,检索时间为 2023 年 7 月 15 日至 7 月 30 日。该范围综述遵循 Arksey 和 O'Malley 框架,并根据系统评价和荟萃分析扩展的首选报告项目报告数据。
综述共纳入 16 项研究。在透析过程中,关于趾收缩压和趾肱血压指数的重要性的数据有限。研究中使用的趾肱血压指数正常值存在差异,且对于用于确定趾收缩压和趾肱血压指数的测量方案的报告有限。
综述发现,关于接受透析治疗的患者群体中趾收缩压和趾肱血压指数的临床实用性的数据有限。使用趾收缩压和趾肱指数来识别该人群中的外周动脉疾病很重要。然而,关于测量方案、可靠性、诊断准确性和预后能力的证据有限且存在矛盾信息。